SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chaodong Wang, Yanning Cai, Zhuqin Gu, Jinghong Ma, Zheng Zheng, Bei-Sha Tang, Yanming Xu, Yongtao Zhou, Tao Feng, Tao Wang, Sheng-Di Chen, Piu Chan, Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals, Neurobiology of Aging, 2014, 35, 3, 725.e1

    CrossRef

  2. 2
    Maria Elena Battista, Esterina Pascale, Carlo Purcaro, Francesca Passarelli, Emanuela Passarelli, Renzo Guglielmi, Nicola Vanacore, Giuseppe Meco, Clinical subtypes in Parkinson’s disease: the impact of MAPT haplotypes, Journal of Neural Transmission, 2014, 121, 4, 353

    CrossRef

  3. 3
    Neena Singh, Swati Haldar, Ajai K. Tripathi, Matthew K. McElwee, Katharine Horback, Amber Beserra, Iron in Neurodegenerative Disorders of Protein Misfolding: A Case of Prion Disorders and Parkinson's Disease, Antioxidants & Redox Signaling, 2014, 140227074430001

    CrossRef

  4. 4
    Kelvin C. Luk, Virginia M.-Y. Lee, Modeling Lewy pathology propagation in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, S85

    CrossRef

  5. 5
    Hongyan Li, Aishanjiang Yusufujiang, Shaliya Naser, Yi Zhu, Mayinur Maimaiti, Xiaoyan He, Juan Bu, Xuegang Meng, Mingyuan Wang, Jiang Li, Baiting Dina, Lijuan Yang, Zuhere Nayi, Hui Dang, Chengfeng Wang, Dilimulati Amiti, Asiya Aji, Nazuke Yusufu, Yan Jiao, Fengmei Duan, Mutation Analysis of PARK2 in a Uyghur Family with Early-onset Parkinson’s Disease in Xinjiang, China, Journal of the Neurological Sciences, 2014,

    CrossRef

  6. 6
    Madeleine E. Sharp, Karen S. Marder, Lucien Côté, Lorraine N. Clark, William C. Nichols, Jean-Paul Vonsattel, Roy N. Alcalay, Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation, Movement Disorders, 2014, 29, 4
  7. 7
    Kurt A Jellinger, The pathomechanisms underlying Parkinson's disease, Expert Review of Neurotherapeutics, 2014, 14, 2, 199

    CrossRef

  8. 8
    Daniela Berg, Ronald B. Postuma, Bastiaan Bloem, Piu Chan, Bruno Dubois, Thomas Gasser, Christopher G. Goetz, Glenda M. Halliday, John Hardy, Anthony E. Lang, Irene Litvan, Kenneth Marek, José Obeso, Wolfgang Oertel, C. Warren Olanow, Werner Poewe, Matthew Stern, Günther Deuschl, Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease, Movement Disorders, 2014, 29, 4
  9. 9
    Han-Joon Kim, Alpha-Synuclein Expression in Patients with Parkinson's Disease: A Clinician's Perspective, Experimental Neurobiology, 2013, 22, 2, 77

    CrossRef

  10. 10
    Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi, Manuchair Ebadi, Biomarkers in Parkinson’s disease (recent update), Neurochemistry International, 2013, 63, 3, 201

    CrossRef

  11. 11
    Shin-ichiro Kubo, Taku Hatano, Masashi Takanashi, Nobutaka Hattori, Can parkin be a target for future treatment of Parkinson's disease?, Expert Opinion on Therapeutic Targets, 2013, 17, 10, 1133

    CrossRef

  12. 12
    Wei-Lin Chien, Tzeng-Ruei Lee, Shih-Ya Hung, Kai-Hsiang Kang, Ruey-Meei Wu, Ming-Jen Lee, Wen-Mei Fu, Increase of oxidative stress by a novel PINK1 mutation, P209A, Free Radical Biology and Medicine, 2013, 58, 160

    CrossRef

  13. 13
    Saori Miyakawa, Mieko Ogino, Sayaka Funabe, Akiko Uchino, Yasushi Shimo, Nobutaka Hattori, Masaaki Ichinoe, Tetuo Mikami, Makoto Saegusa, Kazutoshi Nishiyama, Hideo Mori, Yoshikuni Mizuno, Shigeo Murayama, Hideki Mochizuki, Lewy body pathology in a patient with a homozygous Parkin deletion, Movement Disorders, 2013, 28, 3
  14. 14
    Rachel M. Bailey, Jason P. Covy, Heather L. Melrose, Linda Rousseau, Ruth Watkinson, Joshua Knight, Sarah Miles, Matthew J. Farrer, Dennis W. Dickson, Benoit I. Giasson, Jada Lewis, LRRK2 phosphorylates novel tau epitopes and promotes tauopathy, Acta Neuropathologica, 2013, 126, 6, 809

    CrossRef

  15. 15
    Andreas Puschmann, Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations, Parkinsonism & Related Disorders, 2013, 19, 4, 407

    CrossRef

  16. 16
    Masako Mukai, Keizo Sugaya, Ichiro Yabe, Yu-ichi Goto, Fusako Yokochi, Kazuhito Miyamoto, Huaying Cai, Hidenao Sasaki, Shiro Matsubara, Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in POLG1, Parkinsonism & Related Disorders, 2013, 19, 9, 821

    CrossRef

  17. 17
    Karen M. Doherty, John Hardy, Parkin disease and the Lewy body conundrum, Movement Disorders, 2013, 28, 6
  18. 18
    Roy N. Alcalay, Anat Mirelman, Rachel Saunders-Pullman, Ming-X Tang, Helen Mejia Santana, Deborah Raymond, Ernest Roos, Martha Orbe-Reilly, Tanya Gurevich, Anat Bar Shira, Mali Gana Weisz, Kira Yasinovsky, Maayan Zalis, Avner Thaler, Andres Deik, Matthew James Barrett, Jose Cabassa, Mark Groves, Ann L. Hunt, Naomi Lubarr, Marta San Luciano, Joan Miravite, Christina Palmese, Rivka Sachdev, Harini Sarva, Lawrence Severt, Vicki Shanker, Matthew Carrington Swan, Jeannie Soto-Valencia, Brooke Johannes, Robert Ortega, Stanley Fahn, Lucien Cote, Cheryl Waters, Pietro Mazzoni, Blair Ford, Elan Louis, Oren Levy, Llency Rosado, Diana Ruiz, Tsvyatko Dorovski, Michael Pauciulo, William Nichols, Avi Orr-Urtreger, Laurie Ozelius, Lorraine Clark, Nir Giladi, Susan Bressman, Karen S. Marder, Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations, Movement Disorders, 2013, 28, 14
  19. 19
    David J. Irwin, Virginia M.-Y. Lee, John Q. Trojanowski, Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies, Nature Reviews Neuroscience, 2013, 14, 9, 626

    CrossRef

  20. 20
    Christos Proukakis, Henry Houlden, Anthony H. Schapira, Somatic alpha-synuclein mutations in Parkinson's disease: Hypothesis and preliminary data, Movement Disorders, 2013, 28, 6
  21. 21
    Sharon L Chan, Dario C Angeles, Eng-King Tan, Targeting leucine-rich repeat kinase 2 in Parkinson's disease, Expert Opinion on Therapeutic Targets, 2013, 17, 12, 1471

    CrossRef

  22. 22
    Eleanna Kara, John Hardy, Henry Houlden, The pallidopyramidal syndromes, Current Opinion in Neurology, 2013, 26, 4, 381

    CrossRef

  23. 23
    M.J. Barrett, J. Hagenah, V. Dhawan, S. Peng, K. Stanley, D. Raymond, A. Deik, S.J. Gross, N. Schreiber-Agus, A. Mirelman, K. Marder, L.J. Ozelius, D. Eidelberg, S.B. Bressman, R. Saunders-Pullman, Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease, Parkinsonism & Related Disorders, 2013, 19, 2, 186

    CrossRef

  24. 24
    Michel Goedert, Maria Grazia Spillantini, Kelly Del Tredici, Heiko Braak, 100 years of Lewy pathology, Nature Reviews Neurology, 2012, 9, 1, 13

    CrossRef

  25. 25
    B. F. L. van Nuenen, R. C. Helmich, M. Ferraye, A. Thaler, T. Hendler, A. Orr-Urtreger, A. Mirelman, S. Bressman, K. S. Marder, N. Giladi, B. P. C. van de Warrenburg, B. R. Bloem, I. Toni, Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism, Brain, 2012, 135, 12, 3687

    CrossRef

  26. 26
    K. C. Luk, V. Kehm, J. Carroll, B. Zhang, P. O'Brien, J. Q. Trojanowski, V. M.- Y. Lee, Pathological  -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice, Science, 2012, 338, 6109, 949

    CrossRef